11 studies found for:    Pegasus
Show Display Options
Rank Status Study
1 Unknown  Evaluating PEGASUS - a Group Intervention for Young People With an Autism Spectrum Disorder
Condition: Efficacy of PEGASUS
Intervention: Behavioral: PEGASUS
2 Completed
Has Results
PEGASUS CRT Study: Atrial Support Study in Cardiac Resynchronization Therapy
Condition: Heart Failure
Intervention: Device: Atrial support pacing through cardiac resynchronization therapy. Device: RENEWAL family of CRT-D devices
3 Recruiting Study of the Efficacy of New Non-invasive Prenatal Tests for Screening for Fetal Trisomies Using Maternal Blood
Conditions: Trisomy 21;   Trisomy 18;   Trisomy 13
Interventions: Other: Integrated prenatal screening for Down's syndrome;   Other: Serum QUAD Assay for aneuploidy screening;   Other: Targeted NIPT assay using ccfDNA in maternal blood;   Other: Un-targeted NIPT assay using ccfDNA in maternal blood;   Other: Harmony™ Test (Ariosa Diagnostics)
4 Completed Footwear Minimalism Study
Condition: Healthy Runners
Interventions: Other: Nike Pegasus;   Other: Nike Free 3.0;   Other: Vibram Five Fingers Shoe
5 Active, not recruiting Randomized Study of Integration Success of Osseotite Dental Implants Placed Using Different Insertion Procedures
Conditions: Partial Edentulism;   Tooth Disease
Interventions: Procedure: High  torque insertion;   Procedure: Low torque insertion
6 Active, not recruiting Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
Conditions: Myocardial Infarction;   Cardiovascular Death;   Atherothrombosis;   Stroke
Interventions: Drug: Ticagrelor 90 mg;   Drug: Ticagrelor 60 mg;   Drug: Ticagrelor Placebo
7 Completed Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal Disease
Conditions: Chronic Hepatitis C;   End Stage Renal Disease
Interventions: Drug: Peginterferon alfa-2a;   Drug: Interferon alfa-2a
8 Active, not recruiting HsTnT in Stable Coronary Artery Disease
Condition: Coronary Artery Disease
Intervention: Other: Progress of CHD
9 Recruiting Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus
Conditions: Uremic Pruritus;   Pruritus
Interventions: Drug: nalbuphine HCl ER tablets 60 mg BID;   Drug: nalbuphine HCl ER tablets 120mg BID;   Drug: Placebo tablets BID
10 Active, not recruiting Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Conditions: Anemia;   Chronic Kidney Disease (CKD)
Interventions: Drug: HX575 epoetin alfa;   Drug: US-licensed epoetin alfa
11 Terminated
Has Results
Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
Conditions: Anaplastic Astrocytoma;   Glioblastoma
Interventions: Drug: trabedersen;   Drug: temozolomide;   Device: Drug delivery system for administration of AP 12009;   Procedure: Placement of Drug Delivery System;   Drug: carmustine;   Drug: lomustine

Indicates status has not been verified in more than two years